Given Imaging has announced publication of guidelines that provide physicians with a framework to use PillCam COLON 2 in daily clinical practice.

The company said the guidelines which were commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) are available online and will be published in the May edition of Endoscopy.

The guidelines describe in detail the indications and contraindications for colon capsule endoscopy, secondly the guidelines establish standards for bowel preparation, including diet regimen, the use of boosters, administering prokinetics and patient education about bowel preparation.

The guidelines also provide protocols for the report and work-up of colon capsule endoscopy results.

Given Imaging president and CEO Homi Shamir said the guidelines will support the company’s efforts to educate physicians regarding the clinical utility and benefit of using PillCam COLON for certain patients for whom colonoscopy might be risky including patients taking blood thinning medications, patients with a higher risk of cardiopulmonary events during or after sedation or those at risk of perforation.

The PillCam Colon 2 video capsule is equipped with two miniature color video cameras (one on each end), a battery and an LED light source.

In order to record the colon, PillCam Colon 2 is ingested by the patient which transmit up to 35 frames per second for approximately 10 hours.

The device data is transferred to a computer that uses Rapid software to compile the video data, which aids physicians to review and report the results of the PillCam study.